Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading
ObjectivesTo investigate the value of contrast-enhanced computer tomography (CT)-based on radiomics in discriminating high-grade and low-grade hepatocellular carcinoma (HCC) before surgery.MethodsThe retrospective study including 161 consecutive subjects with HCC which was approved by the institutio...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.660509/full |
id |
doaj-462c2ae2590d4590a75eb25a9b9c6516 |
---|---|
record_format |
Article |
spelling |
doaj-462c2ae2590d4590a75eb25a9b9c65162021-06-04T13:57:23ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-06-011110.3389/fonc.2021.660509660509Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma GradingWen Chen0Wen Chen1Tao Zhang2Lin Xu3Liang Zhao4Huan Liu5Liang Rui Gu6Dai Zhong Wang7Ming Zhang8Department of Medical Imaging, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Radiology, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaDepartment of Radiology, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaDepartment of Radiology, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaPrecision Medicine Research Center, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaGE Healthcare, Shanghai, ChinaDepartment of Radiology, Shanghai Sixth People’s Hospital, Shanghai, ChinaDepartment of Pathology, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaDepartment of Medical Imaging, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaObjectivesTo investigate the value of contrast-enhanced computer tomography (CT)-based on radiomics in discriminating high-grade and low-grade hepatocellular carcinoma (HCC) before surgery.MethodsThe retrospective study including 161 consecutive subjects with HCC which was approved by the institutional review board, and the patients were divided into a training group (n = 112) and test group (n = 49) from January 2013 to January 2018. The least absolute shrinkage and selection operator (LASSO) was used to select the most valuable features to build a support vector machine (SVM) model. The performance of the predictive model was evaluated using the area under the curve (AUC), accuracy, sensitivity, and specificity.ResultsThe SVM model showed an acceptable ability to differentiate high-grade from low-grade HCC, with an AUC of 0.904 in the training dataset and 0.937 in the test dataset, accuracy (92.2% versus 95.7%), sensitivity(82.5% versus 88.0%), and specificity (92.7% versus 95.8%), respectively.ConclusionThe machine learning-based radiomics reflects a better evaluating performance in differentiating HCC between low-grade and high-grade, which may contribute to personalized treatment.https://www.frontiersin.org/articles/10.3389/fonc.2021.660509/fullradiomicsmachine learningsupport vector machinehepatocellular carcinomagrading |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wen Chen Wen Chen Tao Zhang Lin Xu Liang Zhao Huan Liu Liang Rui Gu Dai Zhong Wang Ming Zhang |
spellingShingle |
Wen Chen Wen Chen Tao Zhang Lin Xu Liang Zhao Huan Liu Liang Rui Gu Dai Zhong Wang Ming Zhang Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading Frontiers in Oncology radiomics machine learning support vector machine hepatocellular carcinoma grading |
author_facet |
Wen Chen Wen Chen Tao Zhang Lin Xu Liang Zhao Huan Liu Liang Rui Gu Dai Zhong Wang Ming Zhang |
author_sort |
Wen Chen |
title |
Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading |
title_short |
Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading |
title_full |
Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading |
title_fullStr |
Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading |
title_full_unstemmed |
Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading |
title_sort |
radiomics analysis of contrast-enhanced ct for hepatocellular carcinoma grading |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2021-06-01 |
description |
ObjectivesTo investigate the value of contrast-enhanced computer tomography (CT)-based on radiomics in discriminating high-grade and low-grade hepatocellular carcinoma (HCC) before surgery.MethodsThe retrospective study including 161 consecutive subjects with HCC which was approved by the institutional review board, and the patients were divided into a training group (n = 112) and test group (n = 49) from January 2013 to January 2018. The least absolute shrinkage and selection operator (LASSO) was used to select the most valuable features to build a support vector machine (SVM) model. The performance of the predictive model was evaluated using the area under the curve (AUC), accuracy, sensitivity, and specificity.ResultsThe SVM model showed an acceptable ability to differentiate high-grade from low-grade HCC, with an AUC of 0.904 in the training dataset and 0.937 in the test dataset, accuracy (92.2% versus 95.7%), sensitivity(82.5% versus 88.0%), and specificity (92.7% versus 95.8%), respectively.ConclusionThe machine learning-based radiomics reflects a better evaluating performance in differentiating HCC between low-grade and high-grade, which may contribute to personalized treatment. |
topic |
radiomics machine learning support vector machine hepatocellular carcinoma grading |
url |
https://www.frontiersin.org/articles/10.3389/fonc.2021.660509/full |
work_keys_str_mv |
AT wenchen radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading AT wenchen radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading AT taozhang radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading AT linxu radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading AT liangzhao radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading AT huanliu radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading AT liangruigu radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading AT daizhongwang radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading AT mingzhang radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading |
_version_ |
1721397462296428544 |